Tarsus Pharmaceuticals, Inc. (TARS)

CIK 1819790 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tarsus Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 20268-K0001819790-26-000066
Sep 9, 202640001842190-26-000011
Sep 9, 202640001827672-26-000013
Sep 9, 202640001827584-26-000013
Sep 4, 20261440001959173-26-006760
Sep 4, 20261440001959173-26-006758
Sep 4, 20261440001959173-26-006753
Sep 4, 20261440001628280-26-060766
Sep 3, 202640001842190-26-000009
Sep 3, 202640001827672-26-000011
Sep 2, 20261440001959173-26-006652
Sep 2, 20261440001628280-26-060042
Sep 2, 20261440001959173-26-006670
Sep 2, 20261440001959173-26-006653
Sep 1, 20261440001959173-26-006607
Sep 1, 20261440001959173-26-006596
Aug 25, 20261440001959173-26-006443
Aug 19, 20261440001959173-26-006221
Aug 13, 2026SCHEDULE 13G/A0001274173-26-000207
Aug 6, 202610-Q0001819790-26-000064
Aug 6, 20268-K0001819790-26-000060
Aug 6, 20268-K0001819790-26-000062
Aug 6, 20268-K0001819790-26-000063
Jul 13, 20268-K0001819790-26-000048
Jul 8, 20268-K0001819790-26-000046